Recommendations for clinical trial evaluation of acute stroke therapies.
about
Acupuncture for dysphagia in acute strokeLaunching invasive, first-in-human trials against Parkinson's disease: ethical considerationsEffects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the ratStem cell therapy for neonatal hypoxic-ischemic encephalopathyStroke, dementia, and drug deliveryInflammation and infection in clinical strokeTreating the acute stroke patient as an emergency: current practices and future opportunities.Voltage-gated cation channel modulators for the treatment of strokeIntravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging studyClinical trial design for endovascular ischemic stroke interventionNew perspectives on developing acute stroke therapy.Neuroprotection in cerebral infarction: the opportunity of new studies.Detrimental effects of tropisetron on permanent ischemic stroke in the rat.Laser therapy in acute stroke treatment.Rodent models of focal cerebral ischemia: procedural pitfalls and translational problemsRODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).A radical approach to stroke therapyNeurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?Animal models of ischemic stroke. Part two: modeling cerebral ischemia.Importance of proper patient selection and endpoint selection in evaluation of new therapies in acute stroke: further analysis of the SENTIS trial.Improving the translation of animal ischemic stroke studies to humans.Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.Animal models of stroke: translational potential at present and in 2050Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke VictimsNeuroprotective agents for the treatment of acute ischemic stroke.Baby STEPS: a giant leap for cell therapy in neonatal brain injuryThe potential of nitric oxide therapeutics in stroke.Clinical issues in animal models of stroke and rehabilitation.Magnesium: potential roles in neurovascular diseaseClimbing STAIRs towards clinical trials with a novel PARP-1 inhibitor for the treatment of ischemic stroke.Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage.Interleukin-1 and neuronal injury.Why have neuro-protectants failed?: lessons learned from stroke trials.Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-response and therapeutic window.Impact of Stroke Therapy Academic Industry Roundtable (STAIR) Guidelines on Peri-Anesthesia Care for Rat Models of Stroke: A Meta-Analysis Comparing the Years 2005 and 2015.Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia.Developing and implementing future stroke therapies: the potential of telemedicine.The potential benefit of stem cell therapy after stroke: an update.Challenges of neuroprotection and neurorestoration in ischemic stroke treatment.
P2860
Q24242690-9FED553E-99B2-4EE9-9109-CDEB4F38AC29Q24289526-A5E13194-24D0-48DB-AB26-961410D1F6A6Q24796019-EDAB9DC6-7E8F-4C32-BBD7-A277479E5A2FQ27003906-32B532D3-7A1A-4F1F-8D0F-45A4D161A137Q28166505-23A9A11D-5086-4303-A506-DD0FB9576476Q28194382-53A61C41-75FA-41DC-8996-C764FAE9803DQ28196628-2F375C09-0306-4BF0-87C2-38CA3142BCB3Q28253754-141C0327-8EAB-4D27-BFCD-919847F54DD4Q28287860-88B23083-9330-48F5-BC71-20D8A89B4E95Q28655392-2BD52408-1127-43FB-93FD-5CB670F6AB34Q30759468-5E1B3184-7EDD-48B3-9CF9-024EEC31453DQ31134847-5E260021-D4FC-4454-BD62-635A20637BFFQ33318585-468E2E60-251D-45DC-A47B-8C6E7E85F405Q33360428-7DAF3618-0B8F-4B20-A536-446BD9E9685BQ33647103-AD72BD26-E525-4737-AEA4-6005422B31D6Q33765349-A6D92B66-B417-4DE6-9CDC-5D46BB6F14C3Q33944177-9BB217DE-8E93-4FC9-AB1E-377905C40D26Q33985590-61D31092-DBAD-4183-807C-758EFBBF5081Q34072182-77124B92-C0AE-4FF3-9020-8397B7855941Q34143633-E224A842-C209-44F9-9D0F-CAC99FBABDC8Q34294669-FB544957-2803-4377-AAB4-9674691CB167Q34617625-BCFFE604-3EAB-4331-91A3-A43B380CDCD9Q34700931-EF0DCF8C-4B60-4BE8-BAF0-F2FA1E07D973Q34901610-55D58905-7A3B-4F8B-901D-E4C0928D9A44Q35029799-A908FF3E-79C3-4712-B379-744F9B07AD0EQ35036473-91414E1D-0CDE-4341-98EF-94ED2BE40E7FQ35051518-C81BB919-DF0D-425C-9774-B61C3FADC484Q35073369-888E9720-DA09-4D69-8EAD-1CC9D5C09F50Q35090267-583743FC-784C-471E-86FF-E5633FCCC93CQ35159997-5BDBAF17-893F-4743-BBC6-1628D459E7A3Q35175919-AC89FF13-1472-4AB0-AFD7-E179E49DDBCCQ35993214-3AC201BD-C612-438F-BB3C-B91DF7F8DE06Q36202191-F726A629-1299-4073-A8D6-3757166926AEQ36245471-DE49D209-7BD7-462F-A263-FA7F32F791B0Q36248866-5C60ADCE-2C55-4B71-908C-9D147B76D05EQ36259741-37079C87-C07E-488D-9BC8-1A4FC0ABDEB0Q36260781-2557AC87-9F0F-442F-AC53-251EDD381AF1Q36293035-7D62EBBF-93BD-456B-A4B1-8A505E2686DDQ36318376-BFA6AD3C-18A8-4E73-8D91-D8F752C0FC19Q36331046-2C62DE2B-793D-49C3-9808-3415B341B4CB
P2860
Recommendations for clinical trial evaluation of acute stroke therapies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Recommendations for clinical trial evaluation of acute stroke therapies.
@ast
Recommendations for clinical trial evaluation of acute stroke therapies.
@en
Recommendations for clinical trial evaluation of acute stroke therapies.
@nl
type
label
Recommendations for clinical trial evaluation of acute stroke therapies.
@ast
Recommendations for clinical trial evaluation of acute stroke therapies.
@en
Recommendations for clinical trial evaluation of acute stroke therapies.
@nl
prefLabel
Recommendations for clinical trial evaluation of acute stroke therapies.
@ast
Recommendations for clinical trial evaluation of acute stroke therapies.
@en
Recommendations for clinical trial evaluation of acute stroke therapies.
@nl
P356
P1433
P1476
Recommendations for clinical trial evaluation of acute stroke therapies.
@en
P2093
Stroke Therapy Academic Industry Roundtable II (STAIR-II)
P304
P356
10.1161/01.STR.32.7.1598
P407
P577
2001-07-01T00:00:00Z